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Summary
Type III secretion systems (T3SSs) are key determi-
nants of virulence in many Gram-negative bacteria,
including animal and plant pathogens. They inject
‘effector’ proteins through a ‘needle’ protruding from
thebacterialsurfacedirectlyintoeukaryoticcellsafter
assembly of a ‘translocator’ pore in the host plasma
membrane. Secretion is a tightly regulated process,
which is blocked until physical contact with a host cell
takes place. Host cell sensing occurs through a distal
needle ‘tip complex’ and translocators are secreted
before effectors. MxiC, a Shigella T3SS substrate, pre-
vents premature effector secretion. Here, we examine
howthedifferentpartsofT3SSsworktogethertoallow
orderly secretion. We show that T3SS assembly and
needle tip composition are not altered in an mxiC
mutant. We ﬁnd that MxiC not only represses effector
secretion but that it is also required for translocator
release. We provide genetic evidence that MxiC acts
downstream of the tip complex and then the needle
during secretion activation. Finally, we show that the
needle controls MxiC release. Therefore, for the ﬁrst
time,ourdataallowustoproposeamodelofsecretion
activation that goes from the tip complex to cytoplas-
mic MxiC via the needle.
Introduction
Type III secretion systems (T3SSs) are key determinants
of virulence in many Gram-negative bacteria, including
animal and plant pathogens. They are protein transport
devices used to inject ‘effector’ proteins into the plasma
membrane or cytoplasm of host cells to manipulate cell
processes. Effectors can modulate intracellular trafficking,
induce apoptosis, provoke reorganization of the cytoskel-
eton and manipulate the immune response (Cornelis,
2006; Galan and Wolf-Watz, 2006). In general, T3SSs or
‘secretons’ consist of four parts: a cytoplasmic ‘bulb’ or
C-ring, a transmembrane region, a hollow ‘needle’protrud-
ing from the bacterial surface, which serves as a secretion
conduit, and a distal needle tip complex. The tip, needle
and transmembrane region, when puriﬁed together, are
known as the ‘needle complex’ or NC (Kubori et al., 1998;
Blocker et al., 2001; Veenendaal et al., 2007).
Shigella ﬂexneri, the causative agent of human bacillary
dysentery, uses a T3SS to inject effector proteins that will
allow invasion and dissemination through the colonic
epithelium. In order to inject effector proteins into host
cells, three proteins known as the ‘translocators’ (IpaB,
IpaC and IpaD in Shigella), are required. IpaB and IpaC
will assemble a pore in the host cell membrane, through
which other virulence effector proteins may then be trans-
located (Blocker et al., 1999; Veenendaal et al., 2007).
Once host cell invasion has occurred, it is followed by
dissemination within the epithelium, which leads to
destruction of the mucosal lining and self-limiting dysen-
tery (Parsot, 1994; Schroeder and Hilbi, 2008).
The determinants of Shigella virulence are mostly
encoded on a large virulence plasmid. Located within the
‘entry region’ are the spa, mxi and ipa operons coding for
components of the type III secretion machinery, translo-
cators and ‘early effector’ proteins, the expression of
which is not controlled by T3SS activity (Parsot, 1994; Le
Gall et al., 2005). They are expressed when the environ-
mental conditions are appropriate for invasion (Le Gall
et al., 2005; Schroeder and Hilbi, 2008). At this point
functional type III secretion devices are built following a
sequential process well-conserved between T3SSs
(recently reviewed in Deane et al., 2009). However,
secretion from the T3SS is blocked until contact with a
host cell membrane generates an activation signal. Addi-
tionally, expression of ‘late effector’ genes (like ipaH),
encoding proteins involved in later stages of infection, is
controlled by the T3SS activity. Indeed, it is prevented by
OspD1, an early secreted effector that represses the tran-
scriptional activator MxiE (Parsot et al., 2005). MxiE tran-
scriptional activation also requires a co-activator, IpgC,
the intrabacterial chaperone of IpaB and IpaC (Mavris
et al., 2002). Once secretion is activated, translocator pro-
teins that will form a pore in the host cell membrane are
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© 2010 Blackwell Publishing Ltdsecreted ﬁrst, followed by the early effectors. Thus, IpgC
is released from its substrates, OspD1 is secreted and the
IpgC–MxiE complex activates transcription of the late
effector genes (Parsot et al., 2005). Expression of a small
subset of genes (including virA) is detected when the
T3SS is not active but increases after secretion is acti-
vated (Le Gall et al., 2005), they will be here referred to as
‘middle effector’ genes.
Akey outstanding question is how theT3SS, needle and
tip complex/translocation pore work together in order to
allow orderly effector translocation. In Shigella, it has been
suggested that the host cell is sensed by the tip complex,
hypothetically composed of four molecules of IpaD and
one molecule of IpaB (Espina et al., 2006; Olive et al.,
2007; Veenendaal et al., 2007; Blocker et al., 2008). Host
cell contact would lead to membrane-insertion of IpaB,
which could trigger a conformational change in the tip
leading to activation of secretion (Veenendaal et al., 2007;
Blocker et al., 2008). Secretion and subsequent tip recruit-
ment of the second component of the translocon, IpaC,
would allow assembly of a pore in the plasma membrane
followed by secretion and translocation of effectors
(Veenendaal et al., 2007; Epler et al., 2009; Roehrich
et al., 2010). However, it is still unknown how secretion is
prevented until contact with a host cell membrane gener-
ates an activation signal and how this signal is transduced
to the cytoplasmic side of the T3SS to trigger its activity.
Several models that could complement each other have
been proposed. The ‘extracellular plug’ model proposes
that the needle tip proteins adopt a conformation that
physically blocks secretion and that after host cell contact
a conformational change ‘opens’ the secretion channel
(Menard et al., 1994; Veenendaal et al., 2007; Blocker
et al., 2008). The ‘intracellular plug’ model suggests that a
gate-keeper family of proteins blocks the T3SS from the
inside, while being partially inserted into the secretion
channel. The activation signal would provoke a conforma-
tional change in the needle tip promoting export of the
gate-keeper protein (Ferracci et al., 2005; Blocker et al.,
2008). The ‘allosteric’ model proposes that the needle
plays an active role in transmitting the activation signal
from the tip to the base of the T3SS (Blocker et al., 2001;
Cordeset al.,2005).Thismodelissupportedbytheﬁnding
thatsomeneedlemutantsshowanalteredtipcomplexand
secretion phenotype (Kenjale et al., 2005; Torruellas et al.,
2005; Veenendaal et al., 2007). However, these are all
‘one-step secretion’ models and none of them explains
how differential secretion of translocators and effectors
occurs, as described at least in Shigella, EPEC,
Pseudomonas and Salmonella (Kubori and Galan, 2002;
Kenjale et al., 2005; Cisz et al., 2008; Wang et al., 2008;
Botteaux et al., 2009).
MxiC from Shigella belongs to the putative T3SS gate-
keeper family including Yersinia YopN/TyeA, EPEC SepL
and Salmonella InvE and SsaL (Pallen et al., 2005). In
addition to sequence similarities between the proteins of
this family, comparison of the MxiC crystal structure with
that of YopN/TyeAfrom Yersinia conﬁrms the high conser-
vation of domain topology between these homologues
(Deane et al., 2008), strongly suggesting a conserved
function. Indeed, all these proteins are involved in the
negative control of T3SS activity (Forsberg et al., 1991;
Iriarte et al., 1998; Kubori and Galan, 2002; Day et al.,
2003; Deng et al., 2004; Ferracci et al., 2005). Recently,
Botteaux et al. (2009) showed that MxiC is a T3SS sub-
strate and that an mxiC mutant secretes effectors consti-
tutively in the absence of any activation signal.
We have further characterized an mxiC mutant and
found that it additionally shows weak and delayed induc-
tion of translocator protein secretion when compared with
the wild-type strain. Furthermore, we have ordered the
involvement of the tip, needle and MxiC, analysing the
secretion phenotype of double mutants combining spe-
ciﬁc mxiC, mxiH (encoding the needle subunit), ipaB and
ipaD mutations. We also show that when compared with
wild-type, the mxiC mutant has a similar needle tip
composition. Taken together, our data lead to a novel
working model of secretion activation that, for the ﬁrst
time, goes from the tip complex to cytoplasmic MxiC via
the needle. Beyond providing important and generalizable
information on regulation of T3SS activation, this work
begins to establish a new paradigm for how the functional
state of macromolecular machines is internally sensed
and regulated.
Results
The Shigella T3SS displays three different functional
states (Veenendaal et al., 2007). ‘Leakage’ is a slow, low-
level Ipa protein secretion prior to host cell contact where
around 5% of Ipa proteins are secreted (Magdalena et al.,
2002; Parsot et al., 2005). ‘Induction’ describes the burst
of Ipa protein secretion upon host cell sensing (Menard
et al., 1994) or addition of Congo red (CR), a small amphi-
patic dye molecule which acts as an artiﬁcial inducer of
T3SS secretion in Shigella (Bahrani et al., 1997). This
event occurs within minutes and at least 50% Ipa proteins
are secreted in 15 min following CR induction (Bahrani
et al., 1997; Magdalena et al., 2002; Parsot et al., 2005).
‘Constitutive secretion’ of Ipa proteins represents an
unregulated and higher level secretion than leakage and
involves not only the Ipa proteins but also the ‘late effec-
tors’ that are involved in later stages of infection. It occurs
in some needle mutants, where it is detectable only after
hours (Kenjale et al., 2005). In the ipaB and ipaD mutant
strains, constitutive secretion is much faster and detect-
able in minutes. It is therefore named ‘fast constitutive
secretion’ (Veenendaal et al., 2007).
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translocator proteins
To examine the role of MxiC in secretion regulation we
generated a non-polar mxiC deletion mutant and analy-
sed its secretion proﬁle. As recently reported (Botteaux
et al., 2009), secretion of effector proteins during over-
night growth (leakage) was increased in the mutant
compared with the wild-type or complemented strains
(Fig. 1A). To further analyse the phenotype of the mxiC
mutant, we investigated its secretion proﬁle following
induction with Congo red. We found that the mxiC mutant
showed much weaker secretion activation overall and
especially of translocator proteins (IpaB, IpaC and IpaD)
when compared with the wild-type strain (Fig. 1B). Addi-
tionally, we observed that sometimes the complemented
strain did not show a fully wild-type secretion proﬁle
(Fig. 1B). Since MxiC prevents effector secretion, we rea-
soned that an excess of MxiC could prevent full induction
of effector secretion. In fact, expression of mxiC from
plasmid pUC19 is higher than in the wild-type strain
(Fig. S1). We therefore cloned mxiC into the IPTG induc-
ible plasmid pACT3 (Dykxhoorn et al., 1996) and titrated
the IPTG concentration in order to modulate mxiC
expression. As we expected, when MxiC expression
increased we observed both a decrease in effector secre-
tion and an increase in translocator secretion (Fig. S1). A
time-course experiment showed that after CR induction
the mxiC mutant shows only weak and signiﬁcantly
delayed induction of secretion of the IpaC translocator
protein (Fig. 1C), while secretion of early effectors (IpgD,
Fig. 1C and IpaA not shown) was constitutive. Analysis of
whole extracts showed that intracellular levels of translo-
cator and early effector genes were essentially unaffected
by mxiC deletion (Fig. S1 and Fig. 2C; except the slight
increase seen in IpgD production), as shown previously
(Botteaux et al., 2009). As also previously described (Bot-
teaux et al., 2009), the late effector protein IpaH was
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Fig. 1. The mxiC mutant is impaired in induction of translocator secretion.
A. Overnight leakage of Shigella wild-type (wt), mutant (ipaB, mxiC) and complemented (mxiC/mxiC
+) strains. Supernatants were collected
from overnight cultures, normalized according to cell density, separated by SDS-PAGE and silver-stained.
B. Protein secretion in response to Congo red induction (CR). Cultures were grown to exponential phase, normalized by optical density and
supernatants were collected from duplicates incubated 15 min at 37°C with or without the artiﬁcial inducer CR, separated by SDS-PAGE and
silver-stained. Where known, the position of the Ipa proteins is indicated on the left.
C. Samples from wild-type and the mxiC mutant were collected at the indicated times (min) after the addition of CR or not and Western
blotted with the indicated antibodies.
D. Total protein expression levels. Bacteria were grown to exponential phase and suspension samples were taken in order to represent the
total protein fraction. Samples were normalized, separated by SDS-PAGE and Western blotted with an antibody against late effector protein
IpaH.
E. Proteins secreted by different strains in response to CR addition. Samples were collected as in Fig. 1B and Western blotted with an
antibody against IpaH.
White lines indicate where lanes were removed, all samples in the same panel were run in the same gel.
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© 2010 Blackwell Publishing Ltd, Molecular Microbiology, 78, 1365–1378expressed by the mxiC mutant under non-activated con-
ditions (Fig. 1D). In addition, we noticed that in the mxiC
mutant, IpaH secretion increased after CR addition
(Fig. 1E). Overall, these results suggest that MxiC posi-
tively regulates translocator release upon secretion acti-
vation, while it inhibits early release of effectors.
The needle transmits the signal for MxiC release
The needle and its tip are involved in the control of
T3SS activity as some mutants in the needle subunit
(MxiH) show an altered tip complex and secretion phe-
notype (Kenjale et al., 2005; Veenendaal et al., 2007).
Particularly interesting for us were mutants mxiH/
mxiHK69A and mxiH/mxiHR83A (hereafter denoted as
mxiHK69A and mxiHR83A), termed ‘effector mutants’
since they secrete translocators after CR addition, yet
are concomitantly unable to secrete effector proteins
(Kenjale et al., 2005), although they express wild-type
levels of those proteins (Fig. 2C). MxiC prevents secre-
tion of effectors and is secreted following induction with
CR (Botteaux et al., 2009; and Fig. 2A). To investigate if
the defect in these ‘effector mutants’ is due to an altered
signal transmission between the needle and the cyto-
plasm that involves MxiC, we analysed MxiC secretion in
strains mxiHK69A and mxiHR83A. Both strains are
unable to secrete MxiC after CR addition (Fig. 2A),
although they express MxiC at wild-type levels (Fig. 2C
and not shown). This result identiﬁes the regulator MxiC
as an ‘early effector’-type secretion substrate that is only
released after translocator secretion.
We hence hypothesized that deletion of mxiC in the
mxiHK69A or mxiHR83A mutant background might liber-
ate the blockage in effector secretion seen in these
mutants. Furthermore, as mxiHK69A and mxiHR83A are
inducible for translocator secretion, if MxiC plays a posi-
tive role in the induction of translocator secretion, an mxiC
mxiHK69A (or mxiC mxiHR83A) mutant should show as
weak an induction of translocators secretion as the single
mxiC mutant. We constructed an mxiC mxiH mutant,
complemented it with mxiHK69A or mxiHR83A and analy-
sed the secretion proﬁle of these strains.As expected, the
mxiC mxiH double mutant did not secrete any of the
translocator or effector proteins (data not shown). We
found that mxiC mxiHK69A (or mxiC mxiHR83A, not
shown) indeed secretes early effectors constitutively
(Fig. 2B and D, middle panel). In addition, secretion of the
late effector IpaH showed the same pattern as in the mxiC
Fig. 2. The defect in effector secretion of the
mxiHK69A strain is due to its inability to
secrete MxiC upon activation.
A. Secretion of MxiC by Shigella wild-type
and mxiH mutant strain complemented with
several mxiH mutants in response to CR
addition. Samples were collected as in Fig. 1B
and Western blotted with aMxiC.
B. Overnight leakage of Shigella strains.
Supernatants were collected from overnight
cultures, normalized, separated by
SDS-PAGE and silver-stained.
C. Total protein expression levels. Bacteria
were grown to exponential phase and
suspension samples were taken in order to
represent the total protein fraction. Samples
were normalized, separated by SDS-PAGE
and Western blotted with the indicated
antibodies.
D. Proteins secreted by different strains in
response to CR addition. Samples were
collected as in Fig. 1B and Western blotted
with antibodies against early effector IpgD,
late effector IpaH and translocator (IpaC and
IpaD) proteins. White lines indicate where
lines were removed, all samples in the same
panel were run in the same gel.
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© 2010 Blackwell Publishing Ltd, Molecular Microbiology, 78, 1365–1378mutant itself (Fig. 2D, upper panel). On the other hand, as
we expected, the mxiC mxiHK69A (or mxiC mxiHR83A,
not shown) showed as weak an induction of translocators
secretion as the single mxiC mutant (Fig. 2D, bottom
panel). These data therefore also point to an important
role for MxiC in translocator release. In addition, they
directly implicate the needle in the release of MxiC, once
the translocator proteins have been secreted, which in
turn allows effector secretion.
MxiC acts downstream of the needle tip in the
regulatory cascade leading to secretion activation
In order to determine the position of MxiC in the regulatory
cascade leading to secretion activation, we wanted to
establish whether the function of IpaB, a tip complex
component, is dominant over that of MxiC. For this, we
used a previously generated ipaB mutant carrying a
C-terminal three-amino-acid deletion (ipaBD3) that
behaves as a constitutive secretor, yet remains invasive
and recruits IpaC to the needle tip (Fig. 3A; Roehrich
et al., 2010). We found that the ipaBD3 mutant secretes
MxiC in non-activated conditions (Fig. 3A) and we hence
hypothesized that it is locked in a secretion ‘on’ confor-
mation (i.e. similar to the secretion activated wild-type).
We deleted mxiC in this background and analysed its
secretion phenotype following CR induction in order to
assess MxiC’s role in translocator protein secretion.
Unlike ipaBD3, that secretes the IpaC and IpaD translo-
cator proteins constitutively, the double mutant mxiC
ipaBD3 showed as weak an induction of translocator
secretion as mxiC (Fig. 3A, anti-IpaC and IpaD Western
blots), though both strains express similar levels of trans-
locator proteins (Fig. 3B). Overall, these results suggest
that MxiC’s function is dominant in the ipaBD3 mutant and
required for translocator secretion.
ipaB and ipaD mutants constitutively secrete effectors
and translocators (Menard et al., 1994). We therefore
wondered whether MxiC still plays a role in translocator
secretion in these mutants that do not have a complete tip
complex (Veenendaal et al., 2007). For this, we made
mxiC ipaB and mxiC ipaD double mutants and analysed
their secretion phenotype following CR induction. The
double mutants have the same phenotype as the single
ipaB or ipaD: constitutive secretion of translocators and
effectors and unresponsiveness to CR (Fig. 3A and not
shown). This result indicates that in the ipaB and ipaD
backgrounds, constitutive secretion of translocators is
independent of MxiC.
The needle still plays a role in signal transduction
during constitutive secretion
As ipaB and ipaD mutants are both constitutive secre-
tors and have no functional tip complex (Veenendaal
et al., 2007), we asked whether, during constitutive
secretion, the needle still plays a role in signal transduc-
tion. We made an mxiH ipaB double mutant, comple-
mented it with mxiH or mxiHK69A and analysed the
secretion phenotypes of these strains following CR
induction. All strains analysed showed similar intra-
cellular levels of MxiC (Fig. 4B). Presence of mutation
mxiHK69A prevents MxiC secretion in both ipaB + and
ipaB mutant backgrounds (Fig. 4A). Furthermore, secre-
tion of the late effector IpaH and ‘middle’ effector VirA
was drastically reduced when mxiHK69A was present
(especially evident in the ipaB mutant background;
Fig. 4A, third and forth panel from top). However, secre-
tion of translocator proteins IpaC and IpaD was not sig-
niﬁcantly altered in the ipaB mxiHK69A background
(Fig. 4A, top two panels). Altogether these results
suggest that even in the presence of a profoundly
Fig. 3. MxiC’s function is dominant in the
ipaBD3 mutant.
A. Analysis of proteins secreted by Shigella
wild-type, mutant (mxiC, ipaB and ipaBD3)
and double mutant (ipaB mxiC and the same
complemented with ipaBD3) strains after CR
induction. Samples were collected as in
Fig. 1B, silver-stained (top panel) and
Western- blotted with antibodies against MxiC
and translocator proteins IpaC and IpaD
(bottom panels). Lines are only used as visual
aids.
B. Total protein expression levels. Samples
were collected as in Fig. 2C and Western
blotted with the indicated antibodies.
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© 2010 Blackwell Publishing Ltd, Molecular Microbiology, 78, 1365–1378altered tip complex, the needle still plays a role in MxiC
release and hence in regulating effector secretion.
T3SS assembly and needle tip composition are not
altered in the mxiC mutant
As secretion was altered in an mxiC mutant, we decided
to investigate if it has a wild-type needle tip complex. To
address this, we analysed the composition of needles
puriﬁed from the mutant. Long needles were puriﬁed as
described previously (Veenendaal et al., 2007) from the
wild-type strain and the mxiC mutant overexpressing the
needle protein MxiH and their Ipa content was analysed
by Western blot (Fig. 5A). We found that when compared
with the wild-type strain, the mxiC mutant has similar
amounts of IpaB, IpaD and IpaC (the latter was low and is
hence not shown) proteins present in needles.
In order to examine if the mxiC mutant could have a
defect in T3SS assembly or number, cultures from the
wild-type, the mxiC mutant and the mxiC complemented
strains were osmotically shocked to produce ‘ghost’ cells
where secretons are observable at the cell periphery
(Blocker et al., 2001). The number of secretons and bases
(secretons without needles, which can be attributed to
assembly of immature and thus incomplete secretons or
caused by the mechanical force applied during the prepa-
ration of ghost cells) was estimated by observation of
negatively stained ghost cells using transmission electron
microscopy (Fig. 5B). Although the total number of secre-
tons in the mxiC mutant was decreased by nearly twofold
when compared with the wild-type or complemented
strains (Fig. 5C, top panel), the percentage of secretons
without needle (bases/secretons) was similar for the three
strains (Fig. 5C, bottom panel). Overall, these data
suggest that the mutant shows no defect in T3SS assem-
bly, although MxiC may also be involved in a mechanism
that regulates the number of T3SSs in each cell.
MxiC localizes to the cytosolic fraction
To investigate MxiC’s localization, bacterial fractions from
wild-type and mxiG strains were prepared by mechani-
cally lysing bacteria. The clariﬁed whole cell extract was
ultracentrifuged on top of a sucrose cushion to generate
three fractions: a top cytosolic fraction, a middle sucrose
cushion fraction – where we expected large soluble
protein complexes to migrate – and a membrane pellet.
The presence of several T3SS proteins in the different
fractions was analysed by Western blot. As controls, we
used inner and outer membrane T3SS proteins, respec-
tively, MxiJ and MxiM. These were detected mostly in the
membrane fraction (Fig. 6), indicating that the overall frac-
tionation procedure was successful. MxiN is a cytosolic
protein that is in a large complex with the ATPase Spa47
(Jouihri et al., 2003; Johnson and Blocker, 2008) and also
a probable component of the T3SS C-ring (Morita-
Fig. 4. The needle is involved in MxiC
release even in the absence of a functional tip
complex.
A. Analysis of proteins secreted after CR
induction by Shigella ipaB mxiH double
mutant complemented with the indicated
plasmids. Samples were collected as in
Fig. 1B and Western blotted with the indicated
antibodies.
B. Total protein expression levels. Samples
were collected as in Fig. 2C and Western
blotted with antibodies against translocator
proteins IpaC and IpaD, late effector IpaH,
‘middle’ effector VirA and MxiC.
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© 2010 Blackwell Publishing Ltd, Molecular Microbiology, 78, 1365–1378Ishihara et al., 2006). MxiN localized to the cytosolic,
sucrose cushion and membrane fractions. The proportion
of MxiN in the different fractions was altered in the mxiG
mutant strain relative to wild-type, suggesting that MxiN
association with the T3SS is partially dependent on the
presence of MxiG, with which it would be expected to
associate at the cytoplasmic face of the inner membrane.
However, MxiC was primarily detectable in the cytoplas-
mic fraction and undetectable in the membrane fraction.
Furthermore, its distribution did not change in the
absence of MxiG. This indicates that under our experi-
mental conditions, MxiC has a largely cytosolic
localization.
Discussion
Type III secretion is a tightly regulated process initiated
only after host cell contact. How the different parts of the
Fig. 5. The Ipa composition of needles and
the morphology of secretons are not altered in
an mxiC mutant.
A. Needles from wild-type and mxiC mutant
strains were isolated as described in
Experimental procedures and Western blotted
with the indicated antibodies (samples were
normalized for the amount of MxiH present in
preparations as detected by silver-stain, not
shown).
B. Pictures show secretons (dark arrows) and
bases (needleless secretons, white arrow)
visualized by transmission EM (as described
in Experimental procedures) for the wild-type
(left) and the mxiC mutant (right) strains.
Scale bar equals 50 nm.
C. Analysis of secreton abundance and
assembly. Number of complete secretons and
bases quantiﬁed from electron micrographs of
osmotically shocked ‘ghost’ cells prepared
from the indicated Shigella strains.
Percentages of secretons (top panel) are
relative to the wild-type strain (that showed
1–2 secretons per image and is set to 100%).
Percentages of bases/secretons (bottom
panel) are calculated for each sample. Data
are derived from two independent
experiments where 20–30 images per sample
where taken. Errors given are standard
deviations. The asterisk ‘*’ indicates that
differences with respect to the number of
secretons were statistically different between
the mxiC mutant strain and both the wild-type
and complemented strains, as calculated with
a Student’s t-test (P < 0.05).
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contact and how the activation signal is transmitted to the
cytoplasm to trigger secretion is not understood. Overall,
our data support a model with gating mechanisms located
at the cytoplasmic face of the T3SS apparatus that
prevent secretion in the absence of activation signals. In
addition, they indicate that the needle plays a key role in
receiving activation signals and transmitting them to the
T3SS base and the gate-keeper protein MxiC to activate
translocator and then effector secretion.
YopN/TyeA from Yersinia, InvE and SsaL from Salmo-
nella and SepL from EPEC/EHEC amongst others belong
to the MxiC family of T3SS secretion regulators (Pallen
et al., 2005). All these proteins prevent effector secretion;
however, their role in translocators secretion is not clear.
In invE, ssaL and sepL mutants, secretion of translocator
is severely impaired (Kubori and Galan, 2002; Coombes
et al., 2004; O’Connell et al., 2004; Deng et al., 2005).
However, it is increased in yopN or tyeA mutants (Fors-
berg et al., 1991; Iriarte et al., 1998; Day et al., 2003;
Ferracci et al., 2005). Recently, it was reported that secre-
tion of translocators was not affected in an mxiC mutant
(Botteaux et al., 2009). Yet, our new data suggest that in
Shigella, MxiC does play a role in induction of translocator
secretion. The mxiC mutant shows weak and delayed
secretion of translocators in response to CR when com-
pared with the wild-type strain (Fig. 1).
Deletion of mxiC in the mxiHK69A and ipaBD3 back-
grounds, which also lead to decreased translocator
release, conﬁrmed our original ﬁnding (Figs 2 and 3). We
found that although the mxiC mutant does not show a
defect in T3SS assembly, the number of secretons was
decreased by 40% when compared with the wild-type
strain. Therefore, it is tempting to speculate that MxiC
could have a feedback role in transcriptional regulation of
T3S machinery-encoding genes, as has been described
for other T3SS regulators (Du et al., 2009). However, the
decrease in the number of secretons cannot account for
the defect in translocator secretion as some double
mutants show this defect in secretion but not others
(compare mxiC ipaB versus mxiC ipaBD3 in Fig. 3, where
both strains express similar levels of translocator proteins;
however, the secretion pattern is different). Although
translocator secretion was impaired in the mxiC mutant, it
still showed a weak response to Congo red. This suggests
that in Shigella, more than one mechanism is involved in
activation of translocator secretion, with one/some still
working in the mxiC mutant.
The mxiC mutant shows at 10-fold reduction in inva-
sion efficiency compared with the wild-type strain (data
not shown), as previously described (Botteaux et al.,
2009). Botteaux and co-workers attributed that to the
premature secretion by the mutant of some effectors.
However, we and others have previously shown that con-
stitutive secretion does not always correlate with a lack
of invasion (Picking et al., 2005; Roehrich et al., 2010).
Additionally, the mxiC mutant shows 60% haemolysis
compared with the wild-type strain (Fig. S2). Since it has
been reported that mutants lacking early effector proteins
are normally haemolytic (Blocker et al., 1999), haemoly-
sis depends on translocator function only. So the defect
in haemolysis showed by the mxiC mutant is most prob-
ably due to its low level of inducible translocator secre-
tion. We therefore suggest that the mxiC mutant’s
decreased ability to invade cells is rather due to impair-
ment in translocator secretion and hence translocon for-
mation. Of course, this defect could also be enhanced by
the decrease in the number of secretons displayed by
the mxiC mutant.
As ipaB and ipaD mutants constitutively secrete both
translocator and effector proteins and neither of them
have a complete tip complex, it was proposed that the
needle is in a closed conformation prior to reception of
the activation signal and that absence of the needle tip
completely deregulates secretion (Parsot et al., 1995;
Veenendaal et al., 2007). However, the mxiC mutant
secretes effectors constitutively and yet the composition
of the needle tip does not seem altered in this mutant.
Evidently, we cannot exclude that needle tips from mxiC
are in a partially/dynamically open conformation, but with
unchanged composition. Still, we have shown that even in
the absence of a tip complex, MxiHK69A blocks MxiC
secretion and as a consequence effector secretion
(Fig. 4). This strongly suggests that prevention of effector
wt
C     S   Mb
mxiG
C     S    Mb
αMxiC
αMxiN
αMxiJ
αMxiM
Fig. 6. Distribution of MxiC within cellular fractions. Bacteria were
fractionated as described in Experimental procedures. Samples
were separated by SDS-PAGE and Western blotted with the
indicated antibodies. Fractions are noted as C: cytosol; S: sucrose
cushion and Mb: membrane. MxiN, a cytoplasmic protein that
associates with the T3SS; MxiJ, a T3SS inner membrane protein
and MxiM, a T3SS outer membrane protein were used as controls.
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mation of the needle tip but to the presence of MxiC inside
the bacteria. Therefore, taken together, our new data
suggest that after completion of the needle and its tip, the
positioning of the tip complex allosterically changes the
conformation of the T3SS needle/apparatus and MxiC is
rightly positioned to prevent effector export (Fig. 7 ‘secre-
tion off’ state).
We have shown that both ipaD and ipaB mutants still
constitutively secrete translocators in the absence of
mxiC. However, we found that MxiC’s function in translo-
cator secretion is dominant in the ipaBD3 mutant as when
mxiC was deleted in this background, translocator secre-
tion went from being constitutive to very weakly inducible,
like in the mxiC mutant (Fig. 3). Therefore, the constitutive
secretion of translocators seen in the ipaB or ipaBD3
mutants has a different cause as only the second is MxiC-
dependent. We hence hypothesize that in non-activated
conditions, a mechanism that represses translocator
secretion, directly or indirectly involving IpaD and/or IpaB,
is put in place. After reception of the activation signal,
such a repression mechanism would be counteracted and
the translocators secreted. Our results strongly suggest
that MxiC is involved in counteracting this repression
(Fig. 7, ‘translocators on’ state). Alternatively or addition-
ally, MxiC could play a role in optimizing the targeting of
the translocators to the export apparatus. As in an ipaD or
ipaB mutant the repression mechanism would not be in
place, deletion of mxiC has no effect. In contrast, mutant
ipaBD3, which is constitutively in an ‘on’ conformation
(Roehrich et al., 2010) needs MxiC to counteract the
repression mechanism. Since MxiC secretion is not
needed for translocator secretion (as an mxiHK69A
mutant that is not able to secrete MxiC has no defect in
translocator secretion), MxiC must be acting from inside
the cell at this point. Therefore, we presume that the
repression mechanism is also intracellular. LcrV, the
Yersinia IpaD homologue, regulates secretion through
interaction with the negative regulator protein LcrG, its
intracytoplasmic chaperone. However, unlike IpaD, LcrV
acts as a positive regulator, as an lcrV mutant shows a
defect in effector secretion (Nilles et al., 1997; Matson
and Nilles, 2001). Yet, very recently it was shown that the
Pseudomonas LcrV homologue PcrV acts as a negative
regulator of effector secretion (Lee et al., 2010). These
authors propose that PcrV controls effector secretion by
assembling into a functional needle tip complex. Interest-
ingly, they also found that the LcrG homologue, PcrG, acts
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Fig. 7. Working model for T3SS regulation of secretion in Shigella. Based on our results we suggest that after the T3SS completion there
are three possible secretion states: ‘secretion off’, ‘translocator secretion on’ and ‘effector secretion on’. ‘Secretion off’ state: following
assembly of the needle and its tip, our data suggest that a putative repressor mechanism (X) is put in place to prevent translocator secretion.
MxiC prevents effectors secretion. ‘Translocators on’ state: Sensing of the host cell by the tip complex transmit a signal to the cytoplasm and
translocator proteins are secreted, our data suggest that MxiC is positively involved in this step. ‘Effector on’ state: Our data indicate that a
second signal, probably transmitted through the needle induces MxiC release and as consequence early effectors are secreted. For simplicity
late effector genes and proteins are not included in the ﬁgure.
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prevent premature effector secretion. Our PcrV/LcrV
homologue IpaD carries its own chaperone at its
N-terminus (Johnson et al., 2007). IpaD deletion mutants
within this region still bind the needle tip yet demonstrate
constitutive secretion (Picking et al., 2005; Espina et al.,
2006; Veenendaal et al., 2007).
The isolation of needle mutants showing an altered tip
complex and secretion phenotype led us and others to
propose that the needle and its tip are involved in regula-
tion of T3SS activity (Kenjale et al., 2005; Torruellas et al.,
2005; Davis and Mecsas, 2007; Veenendaal et al., 2007).
Here we have moved a step forward in our molecular
understanding of how the activation signal is transduced to
the cytoplasm in ﬁnding that the needle plays a role con-
trolling MxiC release after translocator secretion has
occurred. We have demonstrated that the inability of the
needle mutant mxiHK69A to secrete effectors is due to its
defect in MxiC secretion and that even in an ipaB mutant
background(otherwiseaconstitutivesecretor)presenceof
MxiHK69ApreventsMxiCsecretionandasaconsequence
effector secretion (Fig. 4). Therefore, the simplest hypoth-
esis is that after translocator secretion, a second activation
signal is transmitted through the needle to release MxiC
(Fig. 7 ‘effectors on’ state). This signal allows effector
secretion and cannot be transmitted through MxiHK69A
needles. Alternatively or additionally, the presence of
MxiHK69A could provoke a conformational change in the
base of needle complex that could strengthen a putative
interaction of MxiC with theT3SS, preventing its secretion.
Finally, after MxiC release from the T3SS, early effectors
are secreted.As previously reported, secretion of the early
effector OspD1, which acts as a repressor of the transcrip-
tional activator MxiE, together with the increase in the
concentration of free IpgC (the chaperone of secreted
translocators IpaB and IpaC), will then activate the expres-
sion of late effector genes (Parsot et al., 2005; Botteaux
et al., 2009).
In our view, the evidence for two activation signals is
now strong and its existence illustrates how exquisitely
sophisticated T3SSs are. The nature of both activation
signals remains unknown but logically the ﬁrst one should
indicate host cell membrane contact (Veenendaal et al.,
2007) and the second should somehow indicate that a
functional translocon has been assembled at this location
in order to allow secretion of the effectors directly into the
host cell. Recently, it has been shown that sensing of
cytoplasmic pH by intracellular Salmonella causes degra-
dation of the SsaM/SpiC/SsaL regulatory complex, where
SsaLis an MxiC homologue, inducing secretion of effector
proteins (Yu et al., 2010). These authors found that a
translocon deletion mutant responds to the pH shift, indi-
cating that the sensor is not part of the translocon and
suggesting that could instead be the needle subunit itself
or a protein localized towards the base of the secretion
apparatus (Yu et al., 2010).
How MxiC and homologues prevent effector secretion
remains unclear in all systems. Botteaux and co-workers
reported an association of MxiC with Spa47 (Botteaux
et al., 2009), therefore MxiC’s interaction with the T3SS
may occlude an acceptor site for effector proteins. MxiC
fractionates overwhelmingly into the cytosolic fraction
(Fig. 6). In addition, there is some controversy about
the localization of SepL, the EPEC and EHEC MxiC homo-
logue: in EPEC SepLwas found to be cytosolic (O’Connell
et al., 2004) or in both the cytoplasm and the inner mem-
brane (Deng et al., 2005), in EHEC it was detected in both
cytosolic and membrane containing fractions (Kresse
et al., 2000). Therefore, interactions between MxiC and
other proteins within the T3SS apparatus may be transient
and hence lost during the fractionation procedure.Alterna-
tively, at steady state perhaps most MxiC is indeed cyto-
solic but the few molecules that interact with T3SSs
account for its function under non-activated conditions. In
fact, SsaL, the Salmonella SPI-2 MxiC homologue, was
recently found to form part of a regulatory complex that
dissociates from the membrane in response to an increase
in pH leading to effector secretion (Yu et al., 2010).
Although SsaLlocalizes mostly to the cytoplasmic fraction,
a small proportion of the membrane bound protein
co-precipitates with the membrane associated complex
and importantly, it is this fraction that dissociates from the
membrane upon pH increase (Yu et al., 2010).
As a prerequisite to understanding how MxiC regulates
T3SS activation, a detailed examination of its molecular
interaction partners within mutants blocked at different
stages in the secretion activation process will have to be
performed. Our aim for the future will be to use the avail-
able atomic structure of MxiC (Deane et al., 2008) to
understand precisely how MxiC acts to regulate T3SS
secretion.
Experimental procedures
Bacterial strains, plasmids and primers
Table 1 lists the strains and plasmids used in this study.
Shigella ﬂexneri strains were grown in trypticase soy broth
(Becton Dickinson) at 37°C with the appropriate antibiotics at
the following ﬁnal concentrations: ampicillin 100 mgm l
-1,
kanamycin 50 mgm l
-1, tetracycline 15 mgm l
-1.
Construction of non-polar knockout mutant strains
The mxiC mutant was generated by using the Lambda Red
system as described by Datsenko and Wanner (2000).
Brieﬂy, to replace the wild-type mxiC gene, a tetracycline
resistance cassette with 50 pb ﬂanking regions homologous
to the mxiC gene was ampliﬁed from strain TH2788 (Frye
et al., 2006) using the primers mxiC_KO_tetF and mxiC_K-
1374 I. Martinez-Argudo and A. J. Blocker 
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carrying plasmid pKD46 (encoding the Red recombinase
genes), was grown at 30°C to an OD600 of 0.2 and then
induced by adding arabinose to a ﬁnal concentration of 0.2%
during approximately 2 h. When cells reached an OD600 of
~ 0.6, they were made electrocompetent by concentrating
them 100 times and washing them 3 times with ice-cold
water. They were electroporated with 1 mg of the puriﬁed PCR
product described above. Mutants where the mxiC gene has
been replaced by the tetracycline cassette were selected on
plates with tetracycline. The same procedure was used to
inactivate mxiC in strains SF620 (ipaB) and SH116 (mxiH)
giving rise to strains mxiC ipaB and mxiC mxiH respectively.
To construct strain ipaB mxiH, the ipaB gene was exchanged
for a tetracycline cassette in the single mutant strain SH116
(mxiH) using the same method. All gene replacements were
conﬁrmed by sequencing.
Construction of plasmids
To complement the mxiC mutant, mxiC was ampliﬁed by PCR
from the M90T virulence plasmid pWR100 using primers
Table 1. Bacterial strains and plasmids used in this study.
Shigella strains Strain/plasmid Reference
M90T Wild-type M90T, serotype 5a Sansonetti et al. (1982)
SF620 ipaB mutant Menard et al. (1993)
mxiG mxiG mutant Allaoui et al. (1995)
mxiC mxiC KO mutant This study
mxiC/mxiC
+ mxiC mutant/ pIMA208 This study
SH116 mxiH mutant Blocker et al. (2001)
mxiHK69A SH116/pRKmxiHK69A Kenjale et al. (2005)
mxiHD73A SH116/pRKmxiHD73A Kenjale et al. (2005)
mxiC mxiH Double mutant mxiC mxiH This study
mxiC mxiHK69A mxiC mxiH/pRKmxiHK69A This study
ipaBD3 SF620/pDR2 Roehrich et al. (2010)
mxiC ipaB Double mutant mxiC ipaB This study
mxiC ipaBD3 mxiC ipaB/pDR2 This study
ipaB mxiH Double mutant ipaB mxiH This study
ipaB mxiH/ipaB
+ mxiH
+ ipaB mxiH/pIMA216 This study
ipaB mxiH /ipaB
+ mxiHK69A ipaB mxiH/pIMA218 This study
ipaB mxiH /mxiH
+ ipaB mxiH/pRKmxiH This study
ipaB mxiH /mxiHK69A ipaB mxiH/pRKmxiHK69A This study
M90T/ pRK2mxiH Wild-type /pRK2mxiH Veenendaal et al. (2007)
mxiC/pRK2mxiH mxiC/pRK2mxiH This study
Plasmids Description Reference
pDR1 pUC19-ipaB Roehrich et al. (2010)
pDR2 pUC19-ipaB C-terminal three-amino-acid truncation Roehrich et al. (2010)
pIMA208 mxiC gene cloned into pUC19 This study
pIMA216 ipaB and mxiH genes cloned into pUC19 This study
pIMA218 ipaB and mxiHK69A genes cloned into pUC19 This study
pKD46 Plasmid expressing lambda red recombinase Datsenko and Wanner (2000)
pRKmxiH mxiH cloned into a pUC18 derivative Kenjale et al. (2005)
pRKmxiHK69A mxiHK69A cloned into a pUC18 derivative Kenjale et al. (2005)
pRKmxiHD73A mxiHD73A cloned into a pUC18 derivative Kenjale et al. (2005)
pRK2mxiH Plasmid overexpressing mxiH Kenjale et al. (2005)
Table 2. Primers used in this study.
Primer Sequence
a
mxiC_SalI GCACGCGTCGACAACTATAAAGTAGGTGA TGTATGCTTG
mxiC_BamHI CGCGGATCCCTGGATCACTTTTATCTCCTGTTATC
mxiH_RBS_PstI ACTACTGCAGCTAACAGGAGGAATTACATATGAGTGTTACAGTACCGAATGATG
mxiH_XbaI ACTATCTAGATTATCTGAAGTTTTGAATAATTG
mxiC_KO_tetF CATTGGTTTCATACTTAAATTACTAACTATAAAGTAGGTGATGTATGCTTGATGTTAATTAAGACCCACTTTCA
TAATTAAGACCCACTTTCA
mxiC_KO_tetR TGCTTAAGAAAAGACTGGATCACTTTTATCTCCTGTTATCTAGAAAGCTCCATATGAATATCCTCCTTACTAAGCACTTGTCT
CCTG
a. Restriction sites are underlined.
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digested with SalI and BamHI giving rise to plasmid pIMA208.
pIMA216 and pIMA218 encoding ipaB and mxiH or
mxiHK69A are derivatives of pDR1 that contains ipaB cloned
into pUC19 (Roehrich et al., 2010). mxiH or mxiHK69A were
ampliﬁed by PCR from pRKmxiH or pRKmxiHK69A (Cordes
et al., 2005; Kenjale et al., 2005) using primers mxiH_RB-
S_PstI and mxiH_XbaI. The digested PCR fragments were
cloned into pDR1 digested with PstI and XbaI (downstream of
the ipaB gene). All plasmids were veriﬁed by sequencing.
Analysis of protein synthesis and secretion
Total level of protein expression. Shigella ﬂexneri strains
were grown at 37°C until exponential growth (OD600 ª 1) was
reached. Samples of the cultures, representing the total
protein fraction, were denatured in Laemmli sample buffer,
separated by SDS-PAGE and used for Western blot analysis.
Overnight leakage. Shigella ﬂexneri strains were grown
overnight at 37°C. Bacteria were collected by centrifugation
at 15 000 g for 10 min at 4°C. The ‘stationary phase’ super-
natants were denatured in Laemmli sample buffer, subjected
to SDS gel electrophoresis and Silver-stained (Silver Xpress
kit, Invitrogen).
Congo red induction. Bacteria collected during exponential
growth (OD600 ª 1) were resuspended at OD600 = 5i n
phosphate-buffered saline. Congo red was added (ﬁnal con-
centration of 200 mgm l
-1) to induce T3SS activity. After incu-
bation at 37°C for 15 min, the samples were centrifuged at
15 000 g for 10 min at 4°C and the supernatants were dena-
tured, separated by SDS-PAGE and Silver-stained or used
for Western blot analysis.
Mouse monoclonal antibodies (Mabs) used for Ipa protein
detection have been described previously and were gener-
ous gifts from Armelle Phalipon (aIpaB, known as H16, and
aIpaC, a mixture of two Mabs known as K24 and J22) and
Kirsten Niebuhr (aIpgD) (Blocker et al., 1999). The rabbit
polyclonal sera against IpaH (Mavris et al., 2002) and IpaD
(Blocker et al., 1999) are also published and were kind gifts of
Regis Tournebize and Claude Parsot respectively. The MxiC
rabbit polyclonal antibody was raised (Eurogentec, Belgium)
against a fragment of MxiC, puriﬁed as a recombinant
polypeptide encompassing MxiC residues 74–355 and carry-
ing an N-terminal His tag with a thrombin cleavage site
(Deane et al., 2008), which was a kind gift from Janet Deane
and Susan Lea. The rabbit polyclonal anti-MxiN serum is
described in Johnson and Blocker (2008), the mouse mono-
clonal antibody against MxiJ and the affinity puriﬁed poly-
clonal anti-MxiM rabbit antibodies in Zenk et al. (2007).
Electron microscopy
Ghost cells were prepared by osmotic shock treatment of
bacterial cultures grown to an OD600 of 1 using glass beads as
described previously (Kenjale et al., 2005). Samples were
deposited onto 300-mesh, Formvar and carbon-coated glow-
discharged copper grids and subsequently stained for 1 min
with 2% phosphotungstic acid at pH 7. Electron microscopy
images were taken on a Tecnai 12 transmission electron
microscope (FEI) operating at 120 KeV. Micrographs were
recorded at a magniﬁcation of 20 000 on an Eagle 4K ¥ 4K
CCD camera (FEI) using the TIA software (FEI). Secretons
and bases were counted by hand.
Needle preparations
Needles were puriﬁed from strains containing the pRK2mxiH
plasmid as previously described (Cordes et al., 2005), in the
absence of T3SS activation. Isolated needles were passed
over a Superdex S200 HR16/30 column equilibrated in
20 mm Tris-HCl pH 7.4, 150 mm NaCl. One-millilitre fractions
were collected and precipitated with trichloroacetic acid
(TCA). Samples were separated by SDS-PAGE and Silver-
stained to normalize the amount of MxiH prior to Western
blotting with appropriate antibodies.
Fractionation of bacteria
Around 400 ml of bacteria was grown to an OD600 of 1 and
pelleted by centrifugation at 4000 g for 10 min. Pellets were
resuspended in 10 ml of Tris buffer (20 mm Tris, 150 mm
NaCl, pH 7.4) and cells were lysed by two passages through
a French Press at 10 000 Pa and a few crystals of DNase I
were added to reduce sample viscosity. Unbroken cells were
removed by several rounds of centrifugation (10 min at
10 000 g), until no further pellet was obtained. Cell lysates
(0.66 ml) were added to a TLS 55 Ultraclear centrifuge tube
(Beckman, 347 356) containing 20% w/w sucrose solution
(1.54 ml). Membranes were pelleted by ultracentrifugation at
200 000 g for 1 h at 4°C in an Optima TLX Ultracentrifuge
(Beckman). Three fractions were collected, the ﬁrst two by
always rotating the collection pipette slowly around the tube’s
edge at the solution’s meniscus: the top, cytosol fraction
(0.6 ml, the last 0.06 ml being discarded), the middle,
sucrose cushion fraction and the bottom, membrane pellet,
which was ﬁrst carefully washed with water and then resus-
pended in 0.6 ml Tris buffer. The sucrose fraction was
precipitated with 10% trichloroacetic acid according to con-
ventional procedures and ﬁnally resuspended in 0.6 ml Tris
buffer. Five microlitres of each of the samples was separated
by SDS-PAGE and used for Western blot analysis.
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